Treatment of dysphagia in Parkinson’s disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Dysphagia is frequently present in individuals with Parkinson’s disease (PD). Abnormalities may be localized to the oral, pharyngeal, or esophageal level and may be evident even in the early stages of the disease. Individuals with dysphagia have an increased risk for aspiration, and silent aspiration may be present in up to one-third of patients with PD. The modified barium swallow (MBS) study is the standard screening test for dysphagia in PD, but it is important to remember that esophageal abnormalities may not be visualized on the MBS and a barium esophagram should be considered if the MBS is negative. Surgical treatment may be curative for structural abnormalities such as a Zenker’s diverticulum, but when the problem is due to oropharyngeal or esophageal dysmotility, speech/swallowing therapy is the most effective treatment.

Original languageEnglish (US)
Title of host publicationCurrent Clinical Neurology
PublisherHumana Press Inc.
Pages41-43
Number of pages3
DOIs
StatePublished - Jan 1 2019

Publication series

NameCurrent Clinical Neurology
ISSN (Print)1559-0585

Fingerprint

Barium
Deglutition
Deglutition Disorders
Parkinson Disease
Esophageal Speech
Zenker Diverticulum
Esophageal Motility Disorders
Speech Therapy
Therapeutics

Keywords

  • Aspiration
  • Dysphagia
  • Esophageal
  • Oropharyngeal
  • Zenker’s

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pfeiffer, R. (2019). Treatment of dysphagia in Parkinson’s disease. In Current Clinical Neurology (pp. 41-43). (Current Clinical Neurology). Humana Press Inc.. https://doi.org/10.1007/978-3-319-97897-0_10

Treatment of dysphagia in Parkinson’s disease. / Pfeiffer, Ronald.

Current Clinical Neurology. Humana Press Inc., 2019. p. 41-43 (Current Clinical Neurology).

Research output: Chapter in Book/Report/Conference proceedingChapter

Pfeiffer, R 2019, Treatment of dysphagia in Parkinson’s disease. in Current Clinical Neurology. Current Clinical Neurology, Humana Press Inc., pp. 41-43. https://doi.org/10.1007/978-3-319-97897-0_10
Pfeiffer R. Treatment of dysphagia in Parkinson’s disease. In Current Clinical Neurology. Humana Press Inc. 2019. p. 41-43. (Current Clinical Neurology). https://doi.org/10.1007/978-3-319-97897-0_10
Pfeiffer, Ronald. / Treatment of dysphagia in Parkinson’s disease. Current Clinical Neurology. Humana Press Inc., 2019. pp. 41-43 (Current Clinical Neurology).
@inbook{f63235b74b714d82b139b1f92c9d1454,
title = "Treatment of dysphagia in Parkinson’s disease",
abstract = "Dysphagia is frequently present in individuals with Parkinson’s disease (PD). Abnormalities may be localized to the oral, pharyngeal, or esophageal level and may be evident even in the early stages of the disease. Individuals with dysphagia have an increased risk for aspiration, and silent aspiration may be present in up to one-third of patients with PD. The modified barium swallow (MBS) study is the standard screening test for dysphagia in PD, but it is important to remember that esophageal abnormalities may not be visualized on the MBS and a barium esophagram should be considered if the MBS is negative. Surgical treatment may be curative for structural abnormalities such as a Zenker’s diverticulum, but when the problem is due to oropharyngeal or esophageal dysmotility, speech/swallowing therapy is the most effective treatment.",
keywords = "Aspiration, Dysphagia, Esophageal, Oropharyngeal, Zenker’s",
author = "Ronald Pfeiffer",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-3-319-97897-0_10",
language = "English (US)",
series = "Current Clinical Neurology",
publisher = "Humana Press Inc.",
pages = "41--43",
booktitle = "Current Clinical Neurology",

}

TY - CHAP

T1 - Treatment of dysphagia in Parkinson’s disease

AU - Pfeiffer, Ronald

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Dysphagia is frequently present in individuals with Parkinson’s disease (PD). Abnormalities may be localized to the oral, pharyngeal, or esophageal level and may be evident even in the early stages of the disease. Individuals with dysphagia have an increased risk for aspiration, and silent aspiration may be present in up to one-third of patients with PD. The modified barium swallow (MBS) study is the standard screening test for dysphagia in PD, but it is important to remember that esophageal abnormalities may not be visualized on the MBS and a barium esophagram should be considered if the MBS is negative. Surgical treatment may be curative for structural abnormalities such as a Zenker’s diverticulum, but when the problem is due to oropharyngeal or esophageal dysmotility, speech/swallowing therapy is the most effective treatment.

AB - Dysphagia is frequently present in individuals with Parkinson’s disease (PD). Abnormalities may be localized to the oral, pharyngeal, or esophageal level and may be evident even in the early stages of the disease. Individuals with dysphagia have an increased risk for aspiration, and silent aspiration may be present in up to one-third of patients with PD. The modified barium swallow (MBS) study is the standard screening test for dysphagia in PD, but it is important to remember that esophageal abnormalities may not be visualized on the MBS and a barium esophagram should be considered if the MBS is negative. Surgical treatment may be curative for structural abnormalities such as a Zenker’s diverticulum, but when the problem is due to oropharyngeal or esophageal dysmotility, speech/swallowing therapy is the most effective treatment.

KW - Aspiration

KW - Dysphagia

KW - Esophageal

KW - Oropharyngeal

KW - Zenker’s

UR - http://www.scopus.com/inward/record.url?scp=85066888736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066888736&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-97897-0_10

DO - 10.1007/978-3-319-97897-0_10

M3 - Chapter

T3 - Current Clinical Neurology

SP - 41

EP - 43

BT - Current Clinical Neurology

PB - Humana Press Inc.

ER -